Assessment of healthcare worker preparedness and health literacy for Marburg virus disease in Nigeria: A cross-sectional study. [PDF]
Oisakede EO +8 more
europepmc +1 more source
The neglected continuously emerging Marburg virus disease in Africa: A global public health threat. [PDF]
Srivastava D +13 more
europepmc +1 more source
The mortality, modes of infection, diagnostic tests, and treatments of Marburg virus disease: A systematic review. [PDF]
Alla D +10 more
europepmc +1 more source
Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: a modelling study [PDF]
Qian GY, Jombart T, Edmunds WJ.
europepmc +2 more sources
Clinical features of Marburg virus disease: a review of all reported patients since 1967. [PDF]
Pisapia R +4 more
europepmc +1 more source
Characterization of the Cynomolgus Macaque Model of Marburg Virus Disease and Assessment of Timing for Therapeutic Treatment Testing. [PDF]
Zumbrun EE +28 more
europepmc +1 more source
Marburg Virus Disease: A Comprehensive Review
The Marburg Virus Disease (MVD) caused by Marburg Virus (MARV) and Ravn Virus (RAVV), collectively known as Marburgvirus, is a deadly zoonotic hemorrhagic fever with case fatality rates ranging from 23% to 90%, making it one of the deadliest known diseases. Its sporadic and unpredictable outbreaks and occasional case transfer to non-endemic areas means
openaire +1 more source
Ethiopia's first-ever Marburg virus disease outbreak: Implications for health security in Jordan in the context of labor migration. [PDF]
Al-Tammemi AB, Mukattash TL.
europepmc +1 more source
Marburg virus disease treatments and vaccines: recent gaps and implications. [PDF]
Albakri K +9 more
europepmc +1 more source
Immunoinformatics-guided design of a universal chimeric multi-epitope subunit vaccine against Marburg virus disease and Ravn virus co-infection. [PDF]
Ali S +5 more
europepmc +1 more source

